Nitric Oxide and Cancer: Pathogenesis and Therapy (eBook)

Benjamin Bonavida (Herausgeber)

eBook Download: PDF
2015 | 2015
XXIII, 308 Seiten
Springer International Publishing (Verlag)
978-3-319-13611-0 (ISBN)

Lese- und Medienproben

Nitric Oxide and Cancer: Pathogenesis and Therapy -
Systemvoraussetzungen
149,79 inkl. MwSt
  • Download sofort lieferbar
  • Zahlungsarten anzeigen
Advances in Nitric Oxide and Cancer is a volume that serves to give the latest research on nitric oxide (NO) and cancer. More specifically, the volume reviews significant advances in the application of NO-mediated drugs. The volume explores nitric oxide and its relationship to cancer spanning from its roles in the pathogenesis, prognosis, gene and protein modifications, regulation of resistance to cytotoxics, and therapeutic applications. With chapters written by leading experts, the volume addresses the burgeoning interest in a rapidly advancing field and provides a valuable resource to scientists who have initiated research as well as clinical investigations in their laboratories on the various roles of NO and cancer.

Dr. Benjamin Bonavida is a professor at UCLA's David Geffen School of Medicine for the Department of Microbiology, Immunology, & Molecular Genetics. His other appointments include being a member of the Department of Defense Congressionally Directed Medical Research Program, Member of the National Cancer Institute's SPORE Program, member of the International Scientific Advisory Board of the Israel Cancer Research Foundation, to name a few. He's currently a scientific reviewer for several journals and a member of editorial boards including Journal of Clinical Immunology, International Journal of Oncology, and Cancer Biotherapy & Radiopharmaceuticals.

Dr. Benjamin Bonavida is a professor at UCLA's David Geffen School of Medicine for the Department of Microbiology, Immunology, & Molecular Genetics. His other appointments include being a member of the Department of Defense Congressionally Directed Medical Research Program, Member of the National Cancer Institute's SPORE Program, member of the International Scientific Advisory Board of the Israel Cancer Research Foundation, to name a few. He's currently a scientific reviewer for several journals and a member of editorial boards including Journal of Clinical Immunology, International Journal of Oncology, and Cancer Biotherapy & Radiopharmaceuticals.

Part I: Molecular Cell Signaling by NO in cancer1. Inflammation-associated Carcinogenesis Involved Interaction Between with iNOS/NO and WNT/beta-cateninQiang Du and David A. Geller 2. NO and Genomic StabilityVasily A. Yakovlev3. Targeting Hyponitroxia in Cancer TherapyBryan Oronsky, Neil Oronsky, Michelle Lybeck, Gary Fanger, Jan Scicinski4. Mechanism of NO-dependent Regulation of Invasion and MetastasisAideen E Ryan, Amy J Burke, Francis J Giles, Francis J Sullivan, Sharon A Glynn5. NO Role in Protumorigenesis and HypoxiaLynne-Marie PostovitPart II: S-nitrosylation and cancer6. Impacts of S-nitrosylation in CancerTysha N. Medeiros, Dana M. Jarigese, Melissa A. Edwards and Mark A. Brown7. S-nitrosylation of Cancer CellsAli Bettaieb, Stéphanie Plenchette, Catherine Paul, Véronique Laurens, Sabrina Romagny, Jean-François Jeannin8. Role of S-nitrosylation in Cancer MetastasisSudjit Luanpitpong and Yon RojanasakulPart III: Modulation of anti-tumor immune responses by NO9. NO Immunity and CancerHermes J. Garbán10. Regulation of Anti-tumor Responses by NOPeter Siesjö11. NO Immune Modulation and Tumor GrowthNaveena B. Janakiram and Chinthalapally V. RaoPart IV: Therapeutics and overcoming resistance 12. Role of NO in Chemo-immune ResistanceBenjamin Bonavida 13. Emerging Role of NO-mediated TherapeuticsCian M. McCrudden and Helen O. McCarthy14. PDT and NOEmilia Della Pietra and Valentina Rapozzi15. Regulation of Cell Death by NOJordi Muntané, Francisco Gallardo-Chamizo, Sheila Pereira, Ángela M. De los Santos, Ángeles Rodríguez-Hernández, Luís M. Marín, Jose M. Álamo, Francisco J Padillo16. Discovery and Development of RRx-001Jan Scicinski, Bryan Oronsky, Shoucheng Ning, Gary R Fanger, Susan J Knox, Mark BednarskiPart V: NO Meditated Alterations in Gene Products 17. Nitric Oxide Coagulation and CancerBenjamin A. Derman, Hau C. Kwaan, Malak Elbatarny, Maha Othman  18. Neutrosphyngomyelinase 2Bei Lei Sun and Bulent Mutus

Erscheint lt. Verlag 12.5.2015
Zusatzinfo XXIII, 308 p. 46 illus., 33 illus. in color.
Verlagsort Cham
Sprache englisch
Themenwelt Medizin / Pharmazie Studium
Naturwissenschaften Biologie
Technik
Schlagworte antibacterial drug resistance • cytotoxics • Nitric oxide therapy • nitrosylation • pleiotropic regulator • S-Nitrosylation
ISBN-10 3-319-13611-9 / 3319136119
ISBN-13 978-3-319-13611-0 / 9783319136110
Haben Sie eine Frage zum Produkt?
PDFPDF (Wasserzeichen)
Größe: 6,6 MB

DRM: Digitales Wasserzeichen
Dieses eBook enthält ein digitales Wasser­zeichen und ist damit für Sie persona­lisiert. Bei einer missbräuch­lichen Weiter­gabe des eBooks an Dritte ist eine Rück­ver­folgung an die Quelle möglich.

Dateiformat: PDF (Portable Document Format)
Mit einem festen Seiten­layout eignet sich die PDF besonders für Fach­bücher mit Spalten, Tabellen und Abbild­ungen. Eine PDF kann auf fast allen Geräten ange­zeigt werden, ist aber für kleine Displays (Smart­phone, eReader) nur einge­schränkt geeignet.

Systemvoraussetzungen:
PC/Mac: Mit einem PC oder Mac können Sie dieses eBook lesen. Sie benötigen dafür einen PDF-Viewer - z.B. den Adobe Reader oder Adobe Digital Editions.
eReader: Dieses eBook kann mit (fast) allen eBook-Readern gelesen werden. Mit dem amazon-Kindle ist es aber nicht kompatibel.
Smartphone/Tablet: Egal ob Apple oder Android, dieses eBook können Sie lesen. Sie benötigen dafür einen PDF-Viewer - z.B. die kostenlose Adobe Digital Editions-App.

Buying eBooks from abroad
For tax law reasons we can sell eBooks just within Germany and Switzerland. Regrettably we cannot fulfill eBook-orders from other countries.

Mehr entdecken
aus dem Bereich